FDA Inspection
CBR Systems IncCBR Systems Inc – FDA Inspection, Jun 3, 2009
Record Details
This FDA Inspection record concerns CBR Systems Inc, with an inspection on June 3, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CBR Systems Inc
- Inspection Date
- June 3, 2009
- Product Type
- Biologics
View Company Profile
ID · 13f7b3ed-c206-45d9-b83b-6e6ba12f76e0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 584441
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 1271.75(b)Risk factors, leukocyte-rich cells or tissues
- 21 CFR 1271.195(c)Monitoring-microorganisms where appropriate
- 21 CFR 1271.220(a)Causing contamination, increasing risks
- 21 CFR 1271.230(a)Validation & approval--established procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CBR Systems Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 17, 2025 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| January 17, 2024 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 14, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 14, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CBR Systems Inc
- FDA Inspection 1259463 - 2025-01-17
- FDA Inspection 1227528 - 2024-01-17
- FDA Inspection 1068670 - 2018-09-14
- FDA Inspection 785859 - 2012-06-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.